{"id":408,"date":"2025-11-01T10:59:47","date_gmt":"2025-11-01T10:59:47","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=408"},"modified":"2025-11-01T11:36:02","modified_gmt":"2025-11-01T11:36:02","slug":"china-nmpa-approved-new-drugs-biological-products-adc","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2025\/408.html","title":{"rendered":"China NMPA Approved New Drugs (Biological Products) ADC"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Updated in 2025-10<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ADC<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td>Target<\/td><td>Drug Name<\/td><td>Code<\/td><td>Approved Time<\/td><td>Company<\/td><td>Partner<\/td><td>ADC Design<\/td><\/tr><tr><td>HER2 ADC<\/td><td>Disitamab Vedotin<\/td><td>RC48<\/td><td>2021-06<\/td><td>RameGen<\/td><td>LO: Seagen<\/td><td>Payload: MMAE<br>Linker: MC-VC-PABC<br>DAR: 3.5<\/td><\/tr><tr><td>HER2 ADC<\/td><td>Trastuzumab Rezetecan<\/td><td>SHR-A1811<\/td><td>2025-05<\/td><td>Hengrui<\/td><td><\/td><td>Payload: TOPO1<br>Linker: GGFG<br>DAR: 6<\/td><\/tr><tr><td>HER2 ADC<\/td><td><\/td><td><\/td><td>2025-10<\/td><td>Kelun<\/td><td><\/td><td>Payload: MMAF<br>Linker: K-lock-Va1-OI-PABC<br>DAR: 2<\/td><\/tr><tr><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><\/tr><tr><td>TROP2 ADC<\/td><td>Sacituzumab Tirumotecan<\/td><td><\/td><td>2024-11<\/td><td>Kelun<\/td><td><\/td><td>Payload: TOPO1<br>Linker: CL2A<br>DAR: 7.4<\/td><\/tr><tr><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><\/tr><tr><td>EGFR ADC<\/td><td>Cetuximab Sarotalocan<\/td><td>MRG003<\/td><td>2025-10<\/td><td>Lepu<\/td><td><\/td><td>Payload: MMAE<br>Linker: MC-VC-PABC<br>DAR: 3.8<\/td><\/tr><tr><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><\/tr><tr><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><td><\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Updated in 2025-10 . ADC Target Drug Name Code Approved Time Company Partner ADC Design HER2 &hellip; <a title=\"China NMPA Approved New Drugs (Biological Products) ADC\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2025\/408.html\"><span class=\"screen-reader-text\">China NMPA Approved New Drugs (Biological Products) ADC<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-408","post","type-post","status-publish","format-standard","hentry","category-china-new-drug"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=408"}],"version-history":[{"count":2,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/408\/revisions"}],"predecessor-version":[{"id":411,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/408\/revisions\/411"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}